Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Company Update

18 Oct 2023 13:37

RNS Number : 5640Q
Highbridge Tactical Credit Fund Ltd
18 October 2023
 

18 October 2023

 

 

HIGHBRIDGE TACTICAL CREDIT FUND LIMITED

("HTCF" or the "Company")

 

 

 

Company Update

Compulsory redemption

The Company's board (the Board) has resolved that pursuant to Article 138(2) of the Company's articles of incorporation, and subject to the provisions of The Companies (Guernsey ) Law, 2008 (the Company Law) , the Company will compulsorily redeem the majority of the Ordinary Shares in the Company on the 1 November 2023, leaving two shareholders, holding 1 share each, being the Chairman, Vic Holmes, and director, Steve Le Page, as the Company is required to have at least one member under the Company Law and in order that they may facilitate the placing of the Company into a voluntary liquidation immediately following the redemption.

 

The Board has made the decision to compulsorily redeem these Ordinary Shares to ensure that the current shareholders are treated no less favourably than redemption creditors (being former shareholders) by a liquidator. Under the Company Law, a liquidator is obliged to discharge the claims of creditors ahead of any monies due to shareholders.

 

Compulsory Redemption Date

1 November 2023 

Compulsory Redemption Record Date

31 October 2023

Aggregate amount to be distributed to shareholders

Initially nil with the potential for future distributions net ongoing expenses

Relevant Percentage of Ordinary Shares to be Redeemed

100% of shares less one share held by each director

Compulsory Redemption Price

Based on the NAV realised by the Liquidator from the underlying assets

New ISIN

n/a due to delisting of remaining shares on or around 1 November 2023

 

Shareholders should note that any amount they may ultimately receive in respect of this redemption will vary with the value of the underlying assets and the costs of the liquidation - as is the case for existing creditors of the Company arising from previous redemption events (see the most recent financial report of the Company for details). The Board cannot estimate the value of any of the elements in the underlying AllBlue portfolio due to the complexity of the structure. The apportionment policy for the proceeds of any fines successfully imposed by the FCA is also not known as these fines relate to several years of activity by BlueCrest.

 

The Company's shares will also be suspended from trading on the London Stock Exchange on 1 November 2023. Further, it is intended that immediately following the compulsory redemption, the Company's two shareholders will hold a short notice shareholder meeting to resolve to delist the Company's shares from the London Stock Exchange and appoint a liquidator. The Company also, as a cost saving measure, does not intend to publish its financial statements for the year ended 30 June 2023.

 

AllBlue

The Company's only remaining asset except for cash is the residual holding in AllBlue Limited.

 

Your Board understands the assets of AllBlue currently consist of:

 

1. An interest in the principal value of junior secured notes issued by Fernando JSN plc, with a sale unlikely to take place in the near future.

2. Settlement agreements which were reached in June 2023 in respect of legal claims (the "Claims") that were filed in New York and London in 2018 and 2019 respectively. Once the settlement amounts are received there will be no further recoveries associated with the Claims.

3. Residual investment portfolio positions which the Liquidators of AllBlue will continue to attempt realise for maximum value, but the potential for future significant recoveries is thought to be unlikely.

 

In addition, the FCA (in the form of a FCA Decision Notice) sought to impose a financial penalty of £40,806,700 on BlueCrest Capital Management (UK) LLP (BCMUK) as well as a redress program for non-US investors. According to a FCA Press Release, the FCA considers that between October 2011 and December 2015, BCMUK failed to manage fairly a conflict of interest relating to the allocation of time spent by portfolio managers on an internal fund. BCMUK elected to challenge the FCA Decision Notice and the redress requirement before the Upper Tribunal in the UK. The Upper Tribunal issued a decision on 21st June 2023 that the FCA's approach did not satisfy the necessary legal preconditions for imposing a redress scheme. Whilst the FCA Decision Notice did not disclose the amount of redress being considered for non-US investors an amount of USD 700 million is referenced in the Upper Tribunal decision. Both the FCA and BCMUK were granted permission to appeal the Upper Tribunal decision to an appellate court. Accordingly, the timeline and final outcome of the Upper Tribunal process remains uncertain.

 

A liquidator is obliged to discharge the claims of creditors ahead of any monies due to shareholders, and any future distributions from the Liquidators of AllBlue will be distributed accordingly.

 

 

 

For further information please contact:

Sanne Fund Services (Guernsey) Limited

Company Secretary

 

Tel: +44 (0) 20 3530 3111

 

LEI: 213800397SYHLYFH5961

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFIFEAEDSEDS
Date   Source Headline
6th Jun 20193:29 pmRNSNet Asset Value(s)
5th Jun 20194:54 pmRNSTransaction in Own Shares
4th Jun 20195:14 pmRNSTransaction in Own Shares
29th May 20195:06 pmRNSChange of Company Secretary and Registered Office
29th May 20194:59 pmRNSTransaction in Own Shares
29th May 20191:41 pmRNSNet Asset Value(s)
24th May 20195:13 pmRNSTransaction in Own Shares
22nd May 20195:00 pmRNSTransaction in Own Shares
22nd May 20191:34 pmRNSNet Asset Value(s)
21st May 20195:11 pmRNSTransaction in Own Shares
21st May 20194:59 pmRNSHolding(s) in Company
21st May 20191:47 pmRNSNet Asset Value(s)
16th May 20195:35 pmRNSTransaction in Own Shares
14th May 20195:28 pmRNSTransaction in Own Shares
14th May 20191:10 pmRNSNet Asset Value(s)
3rd May 201911:47 amRNSNet Asset Value(s)
30th Apr 201912:04 pmRNSNet Asset Value(s)
24th Apr 201912:50 pmRNSNet Asset Value(s)
23rd Apr 20191:34 pmRNSNet Asset Value(s)
16th Apr 201912:41 pmRNSNet Asset Value(s)
16th Apr 20197:00 amRNSAnnual Financial Report
5th Apr 20194:29 pmRNSHolding(s) in Company
3rd Apr 20191:05 pmRNSNet Asset Value(s)
2nd Apr 20191:50 pmRNSHolding(s) in Company
26th Mar 201912:16 pmRNSNet Asset Value(s)
26th Mar 20199:42 amRNSStatement re : Liquidation of AllBlue Funds
25th Mar 20195:23 pmRNSTransaction in Own Shares
22nd Mar 201912:46 pmRNSNet Asset Value(s)
21st Mar 20199:24 amRNSHolding(s) in Company
19th Mar 20191:25 pmRNSNet Asset Value(s)
12th Mar 20195:23 pmRNSTransaction in Own Shares
12th Mar 201911:36 amRNSNet Asset Value(s)
11th Mar 201912:25 pmRNSHolding(s) in Company
8th Mar 20195:07 pmRNSTransaction in Own Shares
5th Mar 20191:18 pmRNSNet Asset Value(s)
27th Feb 201912:47 pmRNSNet Asset Value(s)
26th Feb 201910:46 amRNSNet Asset Value(s)
22nd Feb 201910:19 amRNSHolding(s) in Company
20th Feb 20199:41 amRNSNet Asset Value(s)
15th Feb 20194:52 pmRNSStatement re Membership of Audit Committee
12th Feb 201911:13 amRNSNet Asset Value(s)
5th Feb 201912:13 pmRNSNet Asset Value(s)
4th Feb 20195:27 pmRNSTransaction in Own Shares
30th Jan 201911:24 amRNSNet Asset Value(s)
29th Jan 201911:20 amRNSNet Asset Value(s)
23rd Jan 201911:39 amRNSNet Asset Value(s)
16th Jan 201912:26 pmRNSNet Asset Value(s)
10th Jan 20195:18 pmRNSTransaction in Own Shares
9th Jan 20195:29 pmRNSTransaction in Own Shares
8th Jan 20195:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.